Immunogenicity Associated with Aesthetic Botulinumtoxin A: A Survey of Asia-Pacific Physicians’ Experiences and Recommendations

Background:. Most botulinum toxin A (BoNT/A) products contain unnecessary bacterial components that increase the risk of developing neutralizing antibodies (nAbs). Reports of secondary nonresponse and treatment failures (STF) due to nAbs have accompanied a surge in new BoNT/A products. Methods:. To...

Full description

Bibliographic Details
Main Authors: Je-Young Park, MD, Niamh Corduff, MBBS, Jürgen Frevert, PhD, Rungsima Wanitphakdeedecha, MD, MA, MSc, Yates Y.Y. Chao, MD
Format: Article
Language:English
Published: Wolters Kluwer 2022-04-01
Series:Plastic and Reconstructive Surgery, Global Open
Online Access:http://journals.lww.com/prsgo/fulltext/10.1097/GOX.0000000000004217